Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LXRX | MOLN | GNFT | ||
| Company | Lexicon Pharmaceutcl | Molecular Partners Ag ADR | Genfit S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.7500 | 5.29 | 4.33 | ||
| High | 0.8902 | 5.29 | 4.33 | ||
| Low | 0.7300 | 5.29 | 4.17 | ||
| Last | 0.8634 | 5.29 | 4.20 | ||
| Change | +0.0917 | -0.13 | -0.04 | ||
| % Change | +11.88% | -2.49% | -0.94% | ||
| Volume | 9,985,800 | 700 | 5,100 | ||
| 20-Day Average Volume | 4,872,275 | 15,385 | 5,520 | ||
| Previous Close | 0.7717 | 5.42 | 4.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2424 | 5.77 | 5.12 | ||
| 20-Day Raw Stochastic | 9.88% | 11.52% | 1.61% | ||
| 20-Day Relative Strength | 31.42% | 47.03% | 33.86% | ||
| Weighted Alpha | -38.62 | -32.53 | +25.08 | ||
| Today's Opinion | 100% Sell | 8% Sell | 8% Sell | ||
| Previous Opinion | 100% Sell | 8% Buy | 8% Sell | ||
| Last Month's Opinion | 8% Sell | 56% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.46% since 11/15/24 | -0.84% since 11/15/24 | -6.67% since 11/15/24 | ||
| Low | 0.7300 on 11/22/24 | 5.16 on 11/21/24 | 4.17 on 11/22/24 | ||
| High | 1.0000 on 11/18/24 | 6.14 on 11/19/24 | 4.43 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -55.49% since 10/22/24 | -19.56% since 10/22/24 | -29.94% since 10/22/24 | ||
| Low | 0.7300 on 11/22/24 | 5.11 on 11/15/24 | 4.17 on 11/22/24 | ||
| High | 2.0800 on 10/30/24 | 6.90 on 10/25/24 | 6.03 on 11/04/24 | ||
| 3-Month | |||||
| %Chg | -52.82% since 08/22/24 | -21.12% since 08/22/24 | -5.41% since 08/22/24 | ||
| Low | 0.7300 on 11/22/24 | 4.37 on 10/02/24 | 3.89 on 09/06/24 | ||
| High | 2.1750 on 10/18/24 | 7.60 on 10/22/24 | 6.42 on 10/17/24 | ||
| 6-Month | |||||
| %Chg | -48.30% since 05/22/24 | +39.08% since 05/22/24 | -5.41% since 05/22/24 | ||
| Low | 0.7300 on 11/22/24 | 3.60 on 05/31/24 | 3.61 on 06/28/24 | ||
| High | 2.4500 on 07/25/24 | 12.70 on 06/20/24 | 6.42 on 10/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 212,601 | 213,185 | 209,807 | ||
| Shares Outstanding, K | 246,237 | 40,337 | 49,954 | ||
| Annual Sales | 1,200,000 | 7,840,000 | 41,320,000 | ||
| Annual Net Income | -177,120,000 | -69,040,000 | -31,270,000 | ||
| Last Quarter Sales | 1,750,000 | 790,000 | 14,265,000 | ||
| Last Quarter Net Income | -64,810,000 | -18,950,000 | N/A | ||
| 60-Month Beta | 1.24 | 0.98 | 1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/12/24 | -0.57 on 10/31/24 | N/A | ||
| Latest Earnings Date | 11/12/24 | 11/07/24 | 07/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||